minute read
Shortages of the popular injected weight-loss medicines Wegovy (semaglutide) and Zepbound (tirzepatide) aren’t going to end any time soon, according to the U.S. Food and Drug Administration (FDA).
Topics: Press Coverage
13001 East 17th Place
Aurora, CO 80045
303.724.5375
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
